The human leukocyte antigen-presented ligandome of B lymphocytes
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most immunopeptidomic studies either do not consider cysteine modifications18,22,52,54−56 or use cysteinylation as the only cysteine modification allowed in database searches.7,24,27,57”
From Mild Acid Elution and MHC Immunoaffinity Chromatography Reveal Similar Albeit Not Identical Profiles of the HLA Class I Immunopeptidome (2021) · cites this paper as [24]
In the citing paper
“most immunopeptidomic laboratories do not routinely add a cysteine protecting reagent during cell lysis for MHC-IAC.7,8,18,24,27,49,54−57”
From Mild Acid Elution and MHC Immunoaffinity Chromatography Reveal Similar Albeit Not Identical Profiles of the HLA Class I Immunopeptidome (2021) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The immune epitope database 2.0
Vita, R., Zarebski, L., Greenbaum, J. A., Emami, H., Hoof, I., Salimi, N., Damle, R., Sette, A., & Peters, B. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp1004 · Cited by 631 · cited 9×
“We found 253 of the 784 ligands described in the SYFPEITHI database, and 72 out of 263 ligands described in the IEDB.”
BackgroundInfluentialHadrup, S. R., Bakker, A. H., Shu, C. J., Andersen, R. S., van Veluw, J., Hombrink, P., Castermans, E., thor Straten, P., Blank, C., Haanen, J. B., et al. (2009) · Nature Methods · doi:10.1038/nmeth.1345 · Cited by 306 · cited 1×
“The development of MHC exchange tetramers for finding relevant T cell epitopes is instrumental to this approach (18, 19).”
BackgroundSelf-citationSystems-wide Proteomic Analysis in Mammalian Cells Reveals Conserved, Functional Protein Turnover
Cambridge, S. B., Gnad, F., Nguyen, C., Bermejo, J. L., Krüger, M., & Mann, M. (2011) · Journal of Proteome Research · doi:10.1021/pr101183k · Cited by 277
Zarling, A. L., Ficarro, S. B., White, F. M., Shabanowitz, J., Hunt, D. F., & Engelhard, V. H. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.12.1755 · Cited by 213
The Turnover Kinetics of Major Histocompatibility Complex Peptides of Human Cancer Cells
Milner, E., Barnea, E., Beer, I., & Admon, A. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500241-mcp200 · Cited by 122 · cited 2×
“Pulse-chase experiments have shown that some HLA-presented peptides make it to the cell surface within 30 min of the pulse (57).”
BackgroundDiBrino, M., Parker, K. C., Margulies, D. H., Shiloach, J., Turner, R. V., Biddison, W. E., & Coligan, J. E. (1995) · Biochemistry · doi:10.1021/bi00032a005 · Cited by 71
Hillen, N., Mester, G., Lemmel, C., Weinzierl, A. O., Müller, M., Wernet, D., Hennenlotter, J., Stenzl, A., Rammensee, H., & Stevanović, S. (2008) · European Journal of Immunology · doi:10.1002/eji.200838632 · Cited by 43
Research works printed but not linked: 51
- Kenter, 2009, Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia, N. Engl. J. Med, 361, 1838, 10.1056/NEJMoa0810097 · DOI · Paper page
- Falkenburg, 2002, Minor histocompatibility antigens as targets of graft-versus-leukemia reactions, Curr. Opin. Hematol, 9, 497, 10.1097/00062752-200211000-00005 · DOI
- Yewdell, 2003, Making sense of mass destruction: quantitating MHC class I antigen presentation, Nat. Rev. Immunol, 3, 952, 10.1038/nri1250 · DOI · Paper page
- Kessler, 2011, Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes, Nat. Immunol, 12, 45, 10.1038/ni.1974 · DOI
- Vigneron, 2004, An antigenic peptide produced by peptide splicing in the proteasome, Science, 304, 587, 10.1126/science.1095522 · DOI · Paper page
- van Bergen, 2007, Multiple myeloma-reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene, Blood, 109, 4089, 10.1182/blood-2006-08-043935 · DOI
- Scull, 2012, Secreted HLA recapitulates the immunopeptidome and allows in-depth coverage of HLA A*02:01 ligands, Mol. Immunol, 51, 136, 10.1016/j.molimm.2012.02.117 · DOI · Paper page
- Granados, 2012, MHC I-associated peptides preferentially derive from transcripts bearing miRNA response elements, Blood, 119, e181, 10.1182/blood-2012-02-412593 · DOI
- Bade-Doeding, 2011, Mismatches outside exons 2 and 3 do not alter the peptide motif of the allele group B*44:02P, Hum. Immunol, 72, 1039, 10.1016/j.humimm.2011.08.004 · doi:10.1016/j.humimm.2011.08.004
- Mester, 2011, Insights into MHC class I antigen processing gained from large-scale analysis of class I ligands, Cell. Mol. Life Sci, 68, 1521, 10.1007/s00018-011-0659-9 · DOI
- den Haan, 1998, The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism, Science, 279, 1054, 10.1126/science.279.5353.1054 · DOI · Paper page
- den Haan, 1995, Identification of a graft versus host disease-associated human minor histocompatibility antigen, Science, 268, 1476, 10.1126/science.7539551 · doi:10.1126/science.7539551
- Warren, 2006, An antigen produced by splicing of noncontiguous peptides in the reverse order, Science, 313, 1444, 10.1126/science.1130660 · DOI · Paper page
- Bansal, 2010, CD8 T cell response and evolutionary pressure to HIV-1 cryptic epitopes derived from antisense transcription, J. Exp. Med, 207, 51, 10.1084/jem.20092060 · DOI
- Berger, 2010, Viral adaptation to immune selection pressure by HLA class I-restricted CTL responses targeting epitopes in HIV frameshift sequences, J. Exp. Med, 207, 61, 10.1084/jem.20091808 · DOI
- Hombrink, 2011, High-throughput identification of potential minor histocompatibility antigens by MHC tetramer-based screening: feasibility and limitations, PLoS One, 6, e22523, 10.1371/journal.pone.0022523 · DOI
- Hadrup, 2010, MHC-based detection of antigen-specific CD8+ T cell responses, Cancer Immunol. Immunother, 59, 1425, 10.1007/s00262-010-0824-2 · DOI
- Kersey, 2004, The International Protein Index: an integrated database for proteomics experiments, Proteomics, 4, 1985, 10.1002/pmic.200300721 · DOI · Paper page
- Nijveen, 2011, HSPVdb—the Human Short Peptide Variation Database for improved mass spectrometry-based detection of polymorphic HLA-ligands, Immunogenetics, 63, 143, 10.1007/s00251-010-0497-1 · doi:10.1007/s00251-010-0497-1
- Meadows, 1997, The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition, Immunity, 6, 273, 10.1016/S1074-7613(00)80330-1 · DOI · Paper page
- Meyer, 2009, Identification of natural MHC class II presented phosphopeptides and tumor-derived MHC class I phospholigands, J. Proteome Res, 8, 3666, 10.1021/pr800937k · DOI · Paper page
- Admon, 2011, The Human Immunopeptidome Project, a suggestion for yet another postgenome next big thing, Mol. Cell. Proteomics, 10.1074/mcp.O111.011833 · DOI
- Kondo, 2004, Identification of novel CTL epitopes of CMV-pp65 presented by a variety of HLA alleles, Blood, 103, 630, 10.1182/blood-2003-03-0824 · DOI · Paper page
- Heemskerk, 2001, Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex, Proc. Natl. Acad. Sci. U.S.A, 98, 6806, 10.1073/pnas.111162298 · DOI
- Meiring, 2002, Nanoscale LC-MS(n): technical design and applications to peptide and protein analysis, J. Sep. Sci, 25, 557, 10.1002/1615-9314(20020601)25:9<557::AID-JSSC557>3.0.CO;2-F · DOI · Paper page
- Colaert, 2009, Improved visualization of protein consensus sequences by iceLogo, Nat. Methods, 6, 786, 10.1038/nmeth1109-786 · DOI · Paper page
- Hornbeck, 2012, PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse, Nucleic Acids Res, 40, D261, 10.1093/nar/gkr1122 · DOI · Paper page
- Dinkel, 2011, Phospho.ELM: a database of phosphorylation sites—update 2011, Nucleic Acids Res, 39, D261, 10.1093/nar/gkq1104 · DOI · Paper page
- Blom, 1999, Sequence and structure-based prediction of eukaryotic protein phosphorylation sites, J. Mol. Biol, 294, 1351, 10.1006/jmbi.1999.3310 · DOI · Paper page
- Pruitt, 2005, NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins, Nucleic Acids Res, 33, D501, 10.1093/nar/gki025 · DOI · Paper page
- Hubner, 2008, Peptide separation with immobilized pI strips is an attractive alternative to in-gel protein digestion for proteome analysis, Proteomics, 8, 4862, 10.1002/pmic.200800351 · DOI · Paper page
- Rammensee, 1999, SYFPEITHI: database for MHC ligands and peptide motifs, Immunogenetics, 50, 213, 10.1007/s002510050595 · DOI · Paper page
- Bleakley, 2004, Molecules and mechanisms of the graft-versus-leukaemia effect, Nat. Rev. Cancer, 4, 371, 10.1038/nrc1365 · DOI · Paper page
- Goulmy, 1996, Human minor histocompatibility antigens, Curr. Opin. Immunol, 8, 75, 10.1016/S0952-7915(96)80108-7 · DOI · Paper page
- Mutis, 2002, Hematopoietic system-specific antigens as targets for cellular immunotherapy of hematological malignancies, Semin. Hematol, 39, 23, 10.1053/shem.2002.29248 · doi:10.1053/shem.2002.29248
- Laurin, 2010, Immunomonitoring of graft-versus-host minor histocompatibility antigen correlates with graft-versus-host disease and absence of relapse after graft, Transfusion, 50, 418, 10.1111/j.1537-2995.2009.02440.x · DOI
- Zarling, 2006, Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy, Proc. Natl. Acad. Sci. U.S.A, 103, 14889, 10.1073/pnas.0604045103 · DOI · Paper page
- Dudek, 2012, Constitutive and inflammatory immunopeptidome of pancreatic beta-cells, Diabetes, 61, 3018, 10.2337/db11-1333 · DOI
- Chornoguz, 2012, Major histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patients, Mol. Cell. Proteomics, 11, 1457, 10.1074/mcp.M112.019232 · DOI
- Hunt, 1992, Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry, Science, 255, 1261, 10.1126/science.1546328 · DOI · Paper page
- Maier, 1994, Peptide motifs of HLA-A3, -A24, and -B7 molecules as determined by pool sequencing, Immunogenetics, 40, 306, 10.1007/BF00189978 · DOI
- Huczko, 1993, Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling, J. Immunol, 151, 2572, 10.4049/jimmunol.151.5.2572 · DOI · Paper page
- Macdonald, 2002, Identification of a dominant self-ligand bound to three HLA B44 alleles and the preliminary crystallographic analysis of recombinant forms of each complex, FEBS Lett, 527, 27, 10.1016/S0014-5793(02)03149-6 · DOI
- Liu, 2012, The energetic basis underpinning T-cell receptor recognition of a super-bulged peptide bound to a major histocompatibility complex class I molecule, J. Biol. Chem, 287, 12267, 10.1074/jbc.M112.344689 · DOI
- Engelhard, 1978, Induction of secondary cytotoxic T lymphocytes by purified HLA-A and HLA-B antigens reconstituted into phospholipid vesicles, Proc. Natl. Acad. Sci. U.S.A, 75, 5688, 10.1073/pnas.75.11.5688 · DOI
- Meiring, 2005, Mass tag-assisted identification of naturally processed HLA class II-presented meningococcal peptides recognized by CD4+ T lymphocytes, J. Immunol, 174, 5636, 10.4049/jimmunol.174.9.5636 · doi:10.4049/jimmunol.174.9.5636
- van Haren, 2011, HLA-DR-presented peptide repertoires derived from human monocyte-derived dendritic cells pulsed with blood coagulation factor VIII, Mol. Cell. Proteomics, 10, 10.1074/mcp.M110.002246 · DOI · Paper page
- Tan, 2011, Direct quantitation of MHC-bound peptide epitopes by selected reaction monitoring, Proteomics, 11, 2336, 10.1002/pmic.201000531 · DOI · Paper page
- Weinzierl, 2007, Distorted relation between mRNA copy number and corresponding major histocompatibility complex ligand density on the cell surface, Mol. Cell. Proteomics, 6, 102, 10.1074/mcp.M600310-MCP200 · DOI · Paper page
- Yewdell, 2011, DRiPs solidify: progress in understanding endogenous MHC class I antigen processing, Trends Immunol, 32, 548, 10.1016/j.it.2011.08.001 · DOI · Paper page
- Pinkse, 2008, Highly robust, automated, and sensitive online TiO2-based phosphoproteomics applied to study endogenous phosphorylation in Drosophila melanogaster, J. Proteome Res, 7, 687, 10.1021/pr700605z · DOI · Paper page
Cited by
O’Donnell, T. J., Rubinsteyn, A., & Laserson, U. (2020) · Cell Systems · doi:10.1016/j.cels.2020.06.010 · Cited by 440
Bassani-Sternberg, M., Pletscher-Frankild, S., Jensen, L. J., & Mann, M. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.042812 · Cited by 426
Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes
Gee, M. H., Han, A., Lofgren, S. M., Beausang, J. F., Mendoza, J. L., Birnbaum, M. E., Bethune, M. T., Fischer, S., Yang, X., Gomez-Eerland, R., et al. (2018) · Cell · doi:10.1016/j.cell.2017.11.043 · Cited by 272
Laumont, C. M., Daouda, T., Laverdure, J.-P., Bonneil, É., Caron-Lizotte, O., Hardy, M.-P., Granados, D. P., Durette, C., Lemieux, S., Thibault, P., et al. (2016) · Nature Communications · doi:10.1038/ncomms10238 · Cited by 269
Sturm, T., Sautter, B., Wörner, T. P., Stevanović, S., Rammensee, H.-G., Planz, O., Heck, A. J. R., & Aebersold, R. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00386 · Cited by 63
Metadata
- Authors
- Hassan, C., Kester, M. G. D., de Ru, A. H., Hombrink, P., Drijfhout, J. W., Nijveen, H., Leunissen, J. A. M., Heemskerk, M. H. M., Falkenburg, J. H. F., & van Veelen, P. A.
- Venue
- Molecular & Cellular Proteomics
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 12
- Issue
- 7
- Pages
- 1829-1843
- ISSN
- 1535-9476
- Cited by
- 98
- References
- 7
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 2668 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.